Primary sclerosing cholangitis epidemiology and demographics: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Primary sclerosing cholangitis}} | {{Primary sclerosing cholangitis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{DN}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | |||
===Prevalence=== | |||
===Demographics=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 19:02, 8 December 2016
|
Primary sclerosing cholangitis Microchapters |
|
Differentiating Primary sclerosing cholangitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary sclerosing cholangitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Primary sclerosing cholangitis epidemiology and demographics |
|
FDA on Primary sclerosing cholangitis epidemiology and demographics |
|
CDC on Primary sclerosing cholangitis epidemiology and demographics |
|
Primary sclerosing cholangitis epidemiology and demographics in the news |
|
Blogs on Primary sclerosing cholangitis epidemiology and demographics |
|
Directions to Hospitals Treating Primary sclerosing cholangitis |
|
Risk calculators and risk factors for Primary sclerosing cholangitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Epidemiology and Demographics
Incidence
Prevalence
Demographics
References